QLGN Shares Outstanding History
Below is a table of the QLGN shares outstanding history going back to 5/26/2020:

Date QLGN Shares Outstanding

Also see: QLGN Market Cap History
QLGN Historical Shares Outstanding:
+255.97% CAGR
QLGN Historical Shares Outstanding: +255.97% CAGR

Mouse over chart for data details
5/26/2020 ...11/11/2022
Qualigen Therapeutics is a life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics. Co.'s drug compound QN-302 is being developed to target regulatory regions of cancer genes that down-regulate gene expression in multiple cancer pathways. Co.'s anticancer drug candidate, QN-247 is aptamer-based and in development to treat a variety of cancer types, including liquid and solid tumors. Co.'s RAS-F portfolio is designed to suppress the interaction of endogenous RAS with c-RAF, upstream of the KRAS, HRAS and NRAS effector pathways. We show 11 historical shares outstanding datapoints in our coverage of QLGN's shares outstanding history.

Understanding the changing numbers of QLGN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like QLGN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching QLGN by allowing them to research QLGN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree QLGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Qualigen Therapeutics (QLGN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

QNCX Shares Outstanding History
QTRX Shares Outstanding History
RAIN Shares Outstanding History
RANI Shares Outstanding History
RAPT Shares Outstanding History
RARE Shares Outstanding History
RARX Shares Outstanding History
RCEL Shares Outstanding History
RCKT Shares Outstanding History
RCUS Shares Outstanding History
More Healthcare companies »


QLGN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.